Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037461 | 0.93 | MAPK14 (0.43) | MAPK14ACKR3NAMPTCD274HTR1A | |
| SCHEMBL31037240 | 0.88 | ACKR3 (0.43) | MAPK14ACKR3NAMPTCD274HTR1A | |
| SCHEMBL31037355 | 0.85 | NAMPT (0.48) | NAMPTCD274 | |
| SCHEMBL31744280 | 0.84 | MAPK14 (0.46) | MAPK14ACKR3NAMPTCD274HTR1A | |
| SCHEMBL31037288 | 0.82 | MAPK14 (0.42) | MAPK14ACKR3NAMPTCD274TGFBR1 | |
| SCHEMBL31037312 | 0.79 | GPR119 (0.45) | NAMPT | |
| SCHEMBL31037305 | 0.75 | DRD2 (0.58) | MAPK14ACKR3CD274DRD2DRD4 | |
| SCHEMBL4324960 | 0.73 | CD274 (0.58) | MAPK14ACKR3CD274HTR1ADRD2 | |
| SCHEMBL31037320 | 0.73 | MAPT (0.47) | NAMPT | |
| SCHEMBL8404689 | 0.72 | ACKR3 (0.56) | MAPK14ACKR3CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166024-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2024-08-15 | — | — | WO | disclosed |